Similar articles

• The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.

  Cepleanu M, Cajal N, Cernescu C, Sorodoc Y, Aderca I, Tigăeru N, Suciu D, Manu S, Ferra A, Biberimoroianu S, Dobrescu A, Lucian M. Cepleanu M, et al. Rev Roum Virol (1972). 1973;10(1):8-17. Rev Roum Virol (1972). 1973. PMID: 4709858 Clinical Trial. No abstract available.
• [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].

  Unalan H, Ustaçelebi S. Unalan H, et al. Mikrobiyol Bul. 1985 Oct;19(4):218-28. Mikrobiyol Bul. 1985. PMID: 3831724 Turkish.
• Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.

  Okuno Y, Ueda S, Kurimura T, Suzuki N, Yamanishi K. Okuno Y, et al. Biken J. 1971 Sep;14(3):253-8. Biken J. 1971. PMID: 5167868 No abstract available.
• [Current problems in measles. II. Measles vaccines--recent progress].

  Ciufecu E. Ciufecu E. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984 Jul-Sep;29(3):259-78. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984. PMID: 6438773 Review. Romanian. No abstract available.
• Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.

  Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; VAERS team. Asatryan A, et al. Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255204 Review.